MEDIUM confidence: 100% data completeness, but the composite (55) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Net insider -$173K over 180 days (1 open-market buys, 2 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
| Metric (USD) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $26.5B— | $31.4B+18.3% | $34.9B+11.2% | $37.9B+8.7% | $41.5B+9.6% |
| EPS (dil.) | $1.48— | $0.21-85.8% | $4.20+1900.0% | $6.36+51.4% | $7.80+22.6% |
| Free Cash Flow | $5.3B— | $6.3B+19.5% | $9.5B+50.5% | $12.4B+30.9% | $14.4B+15.8% |
| Gross Margin | 73.5% | 73.3%-0.1pp | 75.5%+2.2pp | 77.2%+1.7pp | 77.7%+0.5pp |
| Operating Margin | 2.1% | 3.3%+1.2pp | 14.4%+11.1pp | 19.0%+4.6pp | 21.5%+2.5pp |
| Net Margin | 5.5% | 0.7%-4.8pp | 11.9%+11.2pp | 16.4%+4.5pp | 18.0%+1.6pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth below the analyst consensus of 11.5%/yr (revenue basis).
Base free cash flow $12.1B (avg FY2024–FY2026; latest year $14.4B) · equity value $188.6B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Fewer than 3 analysts refreshed a price target in the last month, so no revision can be computed. Prior quarter: $258 avg across 10 analysts.
Buy-rated share 73% → 70% over ~3 months (-3pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Aug 2026 | $3.27 | $5.90 | +80.4% |
| May 2026 | $3.13 | $3.88 | +24.0% |
| Feb 2026 | $3.05 | $3.81 | +24.9% |
| Dec 2025 | $2.86 | $3.25 | +13.6% |
| Sep 2025 | $2.78 | $2.91 | +4.7% |
| May 2025 | $2.55 | $2.58 | +1.2% |
| Feb 2025 | $2.61 | $2.78 | +6.5% |
| Dec 2024 | $2.44 | $2.41 | -1.2% |
The QScore of 55 indicates a neutral outlook for CRM, driven by its strong profitability and reasonable valuation, with a P/E of 20.8. The stock scores high on profitability, with an ROE of 20.2%, and exhibits strong risk characteristics, with a beta of 1.3. However, its growth score is somewhat lower, at 44, due to moderate revenue growth of 9.6%. The long-term and short-term scores are closely aligned, suggesting a consistent view of the stock's fundamentals.